Summary Case Study - Psychotropic Medicines in Cognitive Disability or Impairment Clinical Care Standard and the Aged Care Quality Standards
This is one of a suite of resources to support aged care providers deliver evidence-based care to older people who receive government funded aged care services.
It has the dual aim of helping aged care providers to understand their role in mitigating the risks of using psychotropic medicines to manage behaviour in older people with cognitive disability or impairment as described in the Psychotropic Medicines in Cognitive Disability or Impairment Clinical Care Standard (2024); and assisting aged care providers meet their obligations to provide quality, evidence-based clinical care, as described in the Aged Care Quality Standards (ACQS).
This resource uses a fictional scenario to follow the sequence of an older person’s care pathway with an in-home aged care provider. The focus is on the systems and processes that should be in place to support high-quality care of an older person living with dementia. The scenario has four sections that can be used individually or together as education for staff in aged care homes. The sections focus on key areas of risk for older people.
- Person-centred care – commencing with the provider, identifying their care needs and the roles and responsibilities for delivering care
- Medication management
- Managing changed behaviours
- Transitions of Care – acute deterioration resulting in hospital admission and discharge
Links to the Psychotropic medicines in cognitive disability or impairment Clinical Care Standard and the related Outcomes in the Aged Care Quality Standards are provided through-out the documents to support evidence based clinical care.
Accessibility - We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.
Copyright - Unless stated otherwise, materials provided are covered by a Creative Commons Attribution-Non-Commercial-No Derivatives (BY-NC-ND) 4.0 International License.
Request permission to reproduce material produced by the Commission by completing this form.